To focus on the real world treat-to-target rate of early rheumatoid arthritis patients who will be treated according to the 2015 American College of Rheumatology Guideline for the Treatment of RA. To explore the factors which influence the treat-to-target outcome.
Resent study showed that rapid progression of cartilage and bone damage could happen on the early state of RA patients, so the clinicians should try the best to stop the trend, such as early diagnosis, early treatment and treat-to-target. But only half of the RA patients could reach low disease activity in the whole world and about 10% in China. The investigators enroll early RA patients who are treated according to the 2015 American College of Rheumatology Guideline. The relevant data are collected and analyzed by the statistician including clinical data, imaging markers, blood samples and patient-reported outcomes every 3 months.
Study Type
OBSERVATIONAL
Enrollment
200
Enrolled patients will be treated according to the 2015 American College of Rheumatology Guideline for the Treatment of RA
the proportion of patients achieving treat to target
calculate the proportion of patients achieving treat to target according to the change of DAS28 score
Time frame: 2018-4-25 to 2022-7-1
the change of Health Assessment Questionnaire Disability Index(HAQ-DI)
the change of Health Assessment Questionnaire Disability Index(HAQ-DI)
Time frame: 2018-4-25 to 2022-7-1
the change of The Work Productivity and Activity Impairment Questionnaire(WPAI)
the change of The Work Productivity and Activity Impairment Questionnaire(WPAI)
Time frame: 2018-4-25 to 2022-7-1
the change of European Quality of Life-5 Dimensions(EQ-5D)
the change of European Quality of Life-5 Dimensions(EQ-5D)
Time frame: 2018-4-25 to 2022-7-1
the change of Short Form 36 Health Survey Questionnaire(SF-36)
the change of Short Form 36 Health Survey Questionnaire(SF-36)
Time frame: 2018-4-25 to 2022-7-1
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.